To help make this website function we have placed cookies on your computer. You can see what cookies we have set at any time.
We'll assume that you're OK to continue using this site.

Don't show me this message again



The News section of the OTCToolbox website provides a mixture of basic business news and Premium News Stories for the OTC/consumer healthcare industry worldwide. You can read the basic business news free of charge. Access to the Premium News Stories is only available as part of an Annual Subscription to the OTCToolbox website. Click the link below to register to receive our regular emails alerting you to all the latest news stories on the website.



Nestlé sees "strong interest" in Skin Health

18 February 2019

The strategic review of Nestlé Skin Health has attracted "very strong interest", with people lining up to be part of the process, according to Nestlé's chief executive officer Mark Schneider. More

US to revamp dietary supplements regulation

14 February 2019

The Food and Drug Administration (FDA) plans to strengthen the regulation of dietary supplements in the US. The regulatory agency describes the move as "one of the most significant modernisations of dietary supplements regulation and oversight in more than 25 years". More


Moberg is divesting OTC to fund MOB-015

14 February 2019

Moberg Pharma is divesting its OTC business to two private-equity firms in a cash deal worth SEK1.43 billion (USD155 million). The Swedish company plans to focus on developing and commercialising MOB-015, its novel topical terbinafine formulation for treating nail fungus. More


Bayer Consumer Health licenses MOB-015

14 February 2019

Bayer Consumer Health has signed an exclusive European licensing agreement for MOB-015, Moberg Pharma's novel topical terbinafine formulation for treating nail fungus. More

Recordati confirmed as chief executive officer

12 February 2019

Recordati reported worldwide sales up by 5.0% to EUR1.35 billion (USD1.52 billion) in 2018, and confirmed Andrea Recordati as chief executive officer following the recent change of ownership. More

Emerging Markets and US lift Sanofi's sales

11 February 2019

Sanofi's Consumer Healthcare business reported worldwide sales up by 1.9% at constant exchange rates in the fourth quarter of 2018. The Emerging Markets region and the US recorded significant growth but sales in Europe dropped back. More

Japan's Taisho declines at home and overseas

4 February 2019

Japan's Taisho Pharmaceutical has reported falling Self-Medication sales at home and overseas, as it prepares to acquire Bristol-Myers Squibb's French consumer healthcare business UPSA. More

Conference Sponsors
  • CIG
  • Fine Foods
  • Orbital Research
  • SIIT
  • Precision